Atlas Trials

COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.

Clinical trial NCT04397757 · COMPLETED

Trial details

NCT number
NCT04397757
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2020-05-13
Primary completion
2021-02-06
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.